innerbuddies gut microbiome testing

Gut Microbiome and Dementia: The Brain-Gut Connection and Cognitive Decline

Dementia doesn’t develop overnight—many researchers now believe that changes starting in the gut may ripple outward to affect the brain. Your gut microbiome (the trillions of microbes living in your digestive tract) communicates with the brain through multiple “brain-gut” pathways that influence inflammation, immune signaling, and even the production of metabolites that shape neural function.

When the microbiome becomes unbalanced—a state often called dysbiosis—it can contribute to a pro-inflammatory environment. Over time, that chronic inflammation may impair brain health by affecting blood flow, increasing oxidative stress, and influencing how the brain’s immune system responds. Gut-related changes may also help explain why some people experience memory and cognitive decline earlier than others.

The good news: the brain-gut connection is modifiable. By supporting a healthier microbiome—through fiber-rich eating patterns, diverse plant foods, adequate hydration, and lifestyle factors that promote beneficial microbial growth—you may help reduce inflammatory signals and strengthen the pathways that support cognition. Let’s explore what the latest research suggests about gut microbiota, dementia risk, and practical, inside-out steps for brain health.

Get Your Gut Microbiome Test Get Your Gut Microbiome Test Subscription for Dementia Support
innerbuddies gut microbiome testing

Dementia

Dementia is a progressive condition, and emerging research highlights the brain–gut connection, where the gut microbiome influences brain health through short-chain fatty acids (SCFAs), immune signaling, and neural pathways like the vagus nerve. When the gut microbiome is imbalanced (dysbiosis) and gut permeability increases, systemic inflammation can fuel neuroinflammation and cognitive decline. This framework helps explain common dementia symptoms such as memory loss, language difficulties, and impaired executive function, and underscores how gut health may affect disease trajectory.

Microbial patterns in dementia often show reduced diversity and lower SCFA–producing bacteria, with higher levels of potentially inflammatory taxa and increased gut permeability. Testing the microbiome can help identify dysbiosis and guide personalized interventions—such as targeted dietary fiber sources, diverse plant-forward foods, fermented foods, and clinician-guided use of probiotics or prebiotics—to support gut barrier function and potentially preserve cognition.

Programs like InnerBuddies offer microbiome testing to inform individualized care in dementia, aiming to tailor nutrition and gut-support strategies alongside standard medical management. While causality and subtypes remain under study, these approaches emphasize inflammation control, metabolic health, and gut–brain communication as part of a broader strategy to support brain health in aging.

  • Reduced butyrate-producing taxa (Faecalibacterium prausnitzii, Roseburia spp., Eubacterium rectale, Anaerostipes spp., Butyrivibrio spp.) are diminished in dementia-associated dysbiosis, potentially lowering SCFA availability and weakening gut barrier function, which may contribute to neuroinflammation.
  • Elevated pro-inflammatory and barrier-disrupting taxa (Enterobacteriaceae such as Escherichia‑Shigella, Bacteroides fragilis group, non–butyrate–producing Lachnospiraceae, Proteobacteria, Fusobacterium, Streptococcus) are linked to higher systemic inflammation and potential cognitive decline.
  • Reduced Akkermansia muciniphila and other barrier-supporting microbes can weaken the intestinal mucous layer, increase permeability, and may exacerbate inflammation linked to cognitive symptoms.
  • SCFA biosynthesis, especially butyrate production, is a key microbial mechanism that supports neuronal function and mitigates neuroinflammation via immune and epigenetic pathways.
  • gut–brain communication via immune signaling and the vagus nerve provides routes for dysbiosis to influence stress responses and cognitive processes.
  • Dysbiosis can shift tryptophan metabolism and indole signaling, influencing serotonin and other neuroactive pathways relevant to mood and cognition.
  • Alterations in bile acids and energy metabolism due to microbiome changes can affect oxidative stress and vascular function, impacting brain resilience and cognitive trajectory.
Get Your Gut Microbiome Test Get Your Gut Microbiome Test Subscription for Dementia Support
innerbuddies gut microbiome testing

Cognitive / neurological topics

Dementia is a progressive condition marked by declining memory, thinking, and the ability to perform everyday activities. While age and genetics are major risk factors, growing research highlights the “brain-gut connection”—the idea that signals traveling between the gastrointestinal tract and the brain can shape inflammation, immune activity, and neurochemistry. In this context, the gut microbiome (the community of microbes living in your intestines) is increasingly studied for its potential role in dementia risk and cognitive decline.

Gut bacteria can influence the brain through several key pathways. They produce metabolites such as short-chain fatty acids (SCFAs), neurotransmitter-related compounds, and other signaling molecules that may support gut barrier integrity and communicate with the nervous system. When gut balance is disrupted—often reflected as dysbiosis—intestinal permeability (“leaky gut”) may increase, allowing inflammatory signals (and sometimes microbial components) to reach circulation. This can contribute to systemic inflammation, which is closely linked with neuroinflammation in the brain and may accelerate cognitive impairment. The microbiome also interacts with the immune system and the vagus nerve, both of which can affect brain function and stress responses.

Evidence suggests that microbiome-related changes may be associated with dementia subtypes and cognitive trajectory, though cause-and-effect is still an evolving area of science. Nonetheless, practical, microbiome-supportive strategies may help protect brain health by targeting inflammation and metabolic health. Approaches such as improving dietary fiber intake, emphasizing diverse plant-based foods, choosing minimally processed options, and supporting healthy gut routines (including regular movement and, when appropriate, discussing probiotics/prebiotics with a clinician) can help foster a microbiome profile linked with better gut barrier function and potentially healthier cognitive outcomes.

  • Memory loss that disrupts daily life
  • Difficulty finding words or following conversations
  • Confusion about time, place, or familiar routines
  • Reduced judgment or problem-solving ability
  • Trouble with planning, organizing, or completing familiar tasks
  • Changes in mood, behavior, or personality (e.g., apathy, irritability, depression)
  • Increased confusion or agitation, especially in unfamiliar environments
Get Your Gut Microbiome Test Get Your Gut Microbiome Test Subscription for Dementia Support
innerbuddies gut microbiome testing

Dementia

This is relevant for people living with dementia or experiencing early, progressive cognitive decline, including those noticing memory problems that interfere with daily life (such as forgetting recent events, repeating questions, or getting lost more easily). It also applies to individuals who have difficulty with language and communication—like trouble finding the right words, following conversations, or maintaining understanding of familiar routines—because gut–brain signaling may influence inflammation and brain function over time.

It’s also relevant for caregivers and family members who observe changes in mood, behavior, or personality (for example apathy, irritability, or depression), and for those dealing with confusion that comes and goes or worsens in new environments. If someone is showing reduced judgment, planning difficulties, or struggles completing familiar tasks, microbiome-supportive strategies may be worth discussing as part of a broader approach focused on metabolic health and reducing inflammatory load.

This information is particularly useful for adults who want an evidence-informed, practical lifestyle angle to support brain health—especially those concerned about chronic inflammation, digestion-related symptoms, or known risk factors that can overlap with gut dysbiosis (such as low dietary fiber intake or high intake of ultra-processed foods). It may also be relevant to clinicians and dementia care teams looking for complementary gut-focused options—like improving fiber, diversifying plants, and considering prebiotic/probiotic discussions—while remembering that microbiome changes are promising but cause-and-effect is still being studied.

Dementia is a relatively common condition worldwide, with prevalence rising sharply with age. Globally, it affects an estimated ~55 million people, and projections suggest this number will continue to grow as populations age. In higher-income countries and many regions with better reporting, prevalence is often estimated around 5–10% in people aged 65 and older, and it roughly doubles every five years after midlife (e.g., higher rates in the 80+ age group).

In everyday clinical practice, the most recognizable symptoms of dementia—such as memory loss that disrupts daily life, difficulty finding words or following conversations, confusion about time or familiar routines, and reduced judgment or problem-solving—are common reasons families seek evaluation. Behavioral and psychological changes (including apathy, irritability, or depression) and increasing confusion or agitation, particularly in unfamiliar environments, are also frequently reported across dementia subtypes. While symptom patterns vary by type (such as Alzheimer’s disease versus vascular dementia), the overall prevalence of these functional and cognitive difficulties increases as age and disease burden accumulate.

Because dementia is progressive, many individuals experience a gradual decline in thinking and everyday functioning over months to years. This progression contributes to the growing public health impact of dementia and the need for prevention-focused research—including emerging work on the “brain–gut connection,” where gut microbiome changes and gut barrier dysfunction may influence neuroinflammation and cognitive decline. Although microbiome science is still evolving and does not yet provide prevalence figures by microbiome pattern, the high and rising overall burden of dementia—~55 million people worldwide—underscores why gut-targeted, inflammation-relevant strategies (like higher fiber intake and diverse minimally processed plant-forward diets) are increasingly discussed in dementia risk and cognitive health research.

Get Your Gut Microbiome Test Get Your Gut Microbiome Test Subscription for Dementia Support
innerbuddies gut microbiome testing

Gut Microbiome and Dementia: How Your Brain-Gut Connection Impacts Cognitive Decline

Dementia is a progressive condition involving worsening memory, thinking, and daily functioning, and while age and genetics are major drivers, emerging research points to a “brain-gut connection.” The gut microbiome can influence brain health by producing metabolites such as short-chain fatty acids (SCFAs) and other signaling molecules that help regulate inflammation and support healthy gut barrier function. In turn, these gut-derived signals may affect neurochemistry and the body’s stress and immune responses—processes that are closely tied to cognitive decline.

When the gut microbiome becomes imbalanced (dysbiosis), intestinal permeability may increase, sometimes described as “leaky gut.” This can allow inflammatory signals and microbial components to reach circulation more easily, potentially promoting systemic inflammation. Systemic inflammation is linked to neuroinflammation in the brain, which may contribute to accelerated cognitive impairment and dementia-related symptom changes such as confusion, difficulty following conversations, and impaired planning or judgment.

The microbiome also communicates with the brain through multiple pathways, including immune signaling and the vagus nerve, helping shape how the brain responds to stress and inflammation over time. Although scientists are still working to clarify cause-and-effect and which dementia subtypes are most affected, the overall pattern suggests that microbiome-supportive habits—like increasing dietary fiber, eating a diverse range of minimally processed plant foods, maintaining healthy bowel routines, and discussing probiotics or prebiotics with a clinician—may help support gut barrier integrity and metabolic health that could be relevant to preserving cognition.

Get Your Gut Microbiome Test Get Your Gut Microbiome Test Subscription for Dementia Support
innerbuddies gut microbiome testing

Gut Microbiome and Dementia

  • Microbial metabolite signaling (SCFAs like butyrate, propionate, acetate) that supports neuronal function and helps regulate neuroinflammation via immune and epigenetic pathways
  • Gut barrier dysfunction and intestinal permeability (“leaky gut”) allowing bacterial components (e.g., LPS/endotoxins) to enter circulation, promoting systemic inflammation that can drive brain neuroinflammation
  • Immune modulation of the gut–brain axis, including altered cytokine production and immune cell trafficking (e.g., monocyte/macrophage activation) that influences neuroinflammatory processes associated with cognitive decline
  • Vagus nerve and enteric nervous system signaling, where gut microbes and microbial metabolites can affect neurotransmitter balance and stress-response circuitry that impacts cognition
  • Tryptophan and neurotransmitter pathway effects (microbial conversion of tryptophan to indoles and downstream metabolites; impacts serotonin and other neuroactive compounds) influencing mood, cognition, and neurochemistry
  • Endotoxemia and metabolic dysregulation (dysbiosis-associated changes in bile acids and energy metabolism) that can contribute to vascular dysfunction and brain health deterioration relevant to dementia risk
  • Oxidative stress amplification through dysbiosis-driven increases in pro-inflammatory mediators and reduced production of protective microbial metabolites, contributing to neuronal damage
  • Altered microbiome–inflammatory feedback loops (changes in bile acids, SCFAs, and immune signaling) that sustain chronic low-grade inflammation and accelerate progression of cognitive symptoms

Dementia has been increasingly linked to the gut microbiome through a “brain–gut connection” in which gut microbes influence brain health via metabolites, immune signaling, and neural pathways. Beneficial gut bacteria produce short-chain fatty acids (SCFAs) such as butyrate, propionate, and acetate, which help support gut barrier integrity and also affect the nervous system. These SCFAs can regulate inflammation and even interact with epigenetic pathways, potentially shaping neuroinflammation and neuronal function—two processes closely tied to cognitive decline.

When the microbiome shifts out of balance (dysbiosis), the intestinal barrier may become more permeable—often described as “leaky gut.” With increased permeability, microbial components like LPS/endotoxins and other inflammatory signals can more easily enter circulation, promoting systemic inflammation. That inflammatory state can trigger or amplify neuroinflammation in the brain, involving changes in immune cell activity (such as monocyte/macrophage activation) and altered cytokine production. Over time, this immune-driven inflammatory feedback loop can contribute to worsening memory, attention, and overall daily functioning.

Gut–brain communication also occurs through the vagus nerve and the enteric nervous system, which allow microbial metabolites to influence stress-response circuitry and neurotransmitter-related pathways. Dysbiosis can further disturb tryptophan metabolism—altering indole-derived compounds that influence mood and cognition by affecting serotonin and other neuroactive signaling. In parallel, dysbiosis may contribute to metabolic dysregulation (including changes in bile acids and energy metabolism), increased oxidative stress, and vascular dysfunction, all of which can worsen brain resilience and potentially accelerate dementia symptom progression.

Get Your Gut Microbiome Test Get Your Gut Microbiome Test Subscription for Dementia Support
innerbuddies gut microbiome testing

Microbial patterns summary

In dementia, researchers often describe a recurring pattern of gut microbiome imbalance (dysbiosis) characterized by reduced diversity and shifts in the relative abundance of key microbial groups that normally support gut barrier and metabolic health. Beneficial bacteria that generate short-chain fatty acids (SCFAs)—especially butyrate-producing taxa—may be reduced, while other organisms associated with inflammatory signaling may become more prominent. Because SCFAs help reinforce the intestinal lining and regulate immune activity, a lower SCFA output can weaken barrier integrity and contribute to a pro-inflammatory internal environment.

A second commonly discussed feature is increased gut permeability (“leaky gut”), which can allow microbial components such as lipopolysaccharide (LPS) and other pro-inflammatory molecules to enter circulation more easily. This can drive systemic inflammation and immune activation, which in turn may promote neuroinflammation in the brain—an important pathway linked to cognitive decline. Alongside this, dysbiosis can perturb tryptophan metabolism and indole-derived signaling molecules, potentially influencing downstream neurotransmitter-related pathways (including serotonin-related regulation) that affect mood, cognition, and stress responsiveness.

Gut–brain communication is thought to be further affected through microbial metabolites and neural/immune signaling routes such as the vagus nerve and immune cytokine pathways. Dementia-associated dysbiosis is frequently linked with changes in microbial metabolic outputs (including bile acid profiles and other energy-related metabolites), which may worsen oxidative stress, vascular function, and brain resilience. While cause-and-effect is still being clarified and may differ by dementia subtype, the overall microbial pattern suggests that microbiomes that better preserve diversity, SCFA production, and gut-barrier function tend to be more supportive of brain health than microbiomes dominated by inflammatory or barrier-disrupting profiles.


Low beneficial taxa

  • Faecalibacterium prausnitzii
  • Roseburia spp.
  • Eubacterium rectale
  • Anaerostipes spp.
  • Butyrivibrio spp.
  • Bifidobacterium spp.
  • Akkermansia muciniphila


Elevated / overrepresented taxa

  • Enterobacteriaceae (e.g., Escherichia-Shigella)
  • Bacteroides fragilis group (incl. Bacteroides spp.)
  • Lachnospiraceae family (non–butyrate-associated members)
  • Proteobacteria (general increase)
  • Fusobacterium spp.
  • Streptococcus spp.


Functional pathways involved

  • Short-chain fatty acid (SCFA) biosynthesis and butyrate production pathways (e.g., butyrate/acetate via acetate-CoA transferase and related fermentation routes)
  • Intestinal barrier integrity and mucin/ECM interactions (Akkermansia- and mucin-related degradation, strengthening mucus layer and epithelial tight junction signaling)
  • Inflammatory lipopolysaccharide (LPS) transport and endotoxin-mediated immune activation (TLR4/NF-κB signaling triggered by increased microbial LPS and permeability)
  • Bile acid metabolism and bile acid–microbiome signaling (primary-to-secondary bile acid conversion affecting FXR/TGR5 pathways and gut–brain immune tone)
  • Tryptophan metabolism and indole/indole-derivative signaling (aryl hydrocarbon receptor modulation; shifts in kynurenine/indole pathways affecting neuroactive signaling)
  • Vagus nerve and microbial metabolite-mediated gut–brain communication (neuroactive metabolite signaling and immune–neural crosstalk through cytokine pathways)
  • Oxidative stress and redox metabolism (microbial pathways generating/mitigating ROS; impacts on antioxidant capacity and neurovascular resilience)


Diversity note

In people with dementia, studies commonly report a gut microbiome shift toward reduced microbial diversity, meaning there are fewer different bacterial species overall and a less balanced mix of beneficial and potentially pro-inflammatory organisms. This loss of diversity often goes along with changes in the relative abundance of taxa that normally help maintain gut barrier integrity and produce key microbial metabolites, particularly short-chain fatty acids (SCFAs). Because SCFAs (including butyrate) support the intestinal lining and help regulate immune tone, lower SCFA-producing capacity can leave the gut environment more vulnerable to inflammation and stress-related signaling.

Dementia-associated dysbiosis is also frequently described as a change in community structure that favors microbes linked with inflammatory signaling and weakens the ecosystem’s metabolic stability. When the community becomes less resilient, microbial outputs—such as bile acid–related metabolites and other gut-derived signaling molecules—may shift in ways that can promote oxidative stress and systemic immune activation. Over time, these changes can contribute to a pro-inflammatory internal environment that is relevant to neuroinflammation pathways in the brain.

Another recurring feature tied to dysbiosis involves impaired gut barrier function, sometimes referred to as increased intestinal permeability or “leaky gut.” With reduced diversity and altered metabolite production, it may be easier for microbial components and inflammatory triggers to cross into circulation, amplifying immune signaling throughout the body. In parallel, disruptions to microbial metabolism—including pathways involving tryptophan-derived metabolites—can further influence gut–brain communication through immune and neural routes, which may align with cognitive symptoms and disease progression across dementia subtypes.


Get Your Gut Microbiome Test Get Your Gut Microbiome Test Subscription for Dementia Support

Why generic solutions fail

  • Issue with generic solutions

    For dementia, generic “one-size-fits-all” gut interventions often fail because the gut–brain link isn’t driven by a single microbe or single pathway. Different people—and different dementia subtypes—can show distinct microbiome shifts in diversity, SCFA-producing capacity, bile acid metabolism, and immune-signaling balance. When an approach isn’t tailored to whether SCFAs/butyrate output is reduced, whether gut barrier function appears compromised (increased permeability), or whether tryptophan/indole signaling is disrupted, it may improve digestion without meaningfully changing the specific inflammatory or metabolic signals most relevant to cognitive decline.

    Another reason generic solutions underperform is that gut microbiome problems in dementia are frequently secondary to broader factors like diet quality, medication use (especially antibiotics and some CNS-related drugs), sleep disruption, frailty, and constipation patterns. A standard probiotic or a fixed prebiotic dose can be less effective if the person’s baseline dysbiosis is not compatible with that strain mix, if fiber intake is too low to support fermentation, or if constipation and altered bowel transit prevent beneficial metabolites from accumulating. In many cases, the limiting factor isn’t simply “adding probiotics,” but restoring an environment that supports beneficial fermenters, reduces barrier stress, and stabilizes immune activation over time.

    Finally, generic plans can miss the practical reality that cognition-related symptoms (forgetting doses, changing meal routines, swallowing issues) can lead to inconsistent adherence, variable dietary intake, and unintended nutrient shortfalls. Without monitoring for tolerability (e.g., excessive gas/bloating from sudden fiber increases), considering medication interactions, and adjusting gradually, interventions may be discontinued or fail to produce sustained microbiome and metabolite changes. Since the relevant mechanisms may involve systemic inflammation, neuroinflammation, and metabolite signaling—not just microbial counts—generic strategies that don’t account for mechanism, baseline gut function, and real-world adherence often show disappointing results.

  • Common mistakes

    • Using one-size-fits-all probiotics/prebiotics without assessing whether the person’s main issue is reduced SCFA/butyrate output, impaired gut barrier/raised permeability, or altered tryptophan/indole signaling—so the intervention doesn’t target the dominant mechanism.
    • Skipping baseline gut context (dietary fiber intake, constipation/slow transit, current microbiome diversity, recent antibiotic/CNS medication use), leading to poor survival/engraftment of beneficial microbes or insufficient substrate for fermentation.
    • Increasing fiber or fermentation abruptly (or using high-dose prebiotics too quickly), which can worsen gas, bloating, and discomfort—causing discontinuation and preventing sustained metabolite and barrier improvements.
    • Assuming symptom improvement equals microbiome correction; not monitoring for relevant downstream signals like stool frequency/consistency, inflammatory/oxidative-stress–related markers, SCFA-supportive stool patterns, or signs of barrier strain.
    • Ignoring medication and adherence realities common in dementia (missed doses, inconsistent meal timing, swallowing issues, reduced intake), which creates variable exposure and undermines any gradual microbiome adaptation.
    • Not accounting for dementia subtype differences and co-factors (frailty, sleep disruption, vascular risk, diet quality, comorbid GI disease), resulting in mismatched microbial targets and incomplete gut–brain pathway modulation.
    • Overlooking gut permeability drivers (dietary emulsifiers/ultra-processed foods, irregular bowel habits, dysregulated bile acid handling, chronic stress) and focusing only on adding microbes rather than reducing barrier stressors.
    • Failing to use mechanism-informed sequencing (e.g., stabilizing transit and diet first, then introducing targeted substrates/strains), which can limit whether beneficial metabolites like SCFAs actually accumulate over time.

What to do

  • General support strategies

    Dementia is a progressive condition marked by declining memory, thinking, and day-to-day functioning, and a growing body of research suggests a meaningful “brain–gut connection.” Your gut microbiome can influence brain health through metabolites and signaling molecules—such as short-chain fatty acids (SCFAs)—that help regulate inflammation and support the gut barrier. When the microbiome and gut lining are well supported, these gut-derived cues may help lower inflammatory load and promote more stable immune and stress responses that are relevant to cognitive function.

    Supporting the microbiome often starts with dietary patterns that increase diversity and fiber. Eating a wide range of minimally processed plant foods—such as legumes, vegetables, whole grains, nuts, seeds, berries, and herbs—feeds beneficial gut microbes and increases the production of SCFAs that help maintain intestinal integrity. It can also be helpful to prioritize consistent meal timing and adequate hydration, while limiting ultra-processed foods and excessive added sugars that may encourage dysbiosis. Maintaining healthy bowel habits matters too, because constipation or irregularity can worsen microbial imbalance and inflammation signaling.

    Because dysbiosis may be linked with increased intestinal permeability (“leaky gut”) and downstream neuroinflammation, general gut-support strategies focus on barrier-friendly nutrition and microbial resilience. Some people consider prebiotics (fiber-like compounds that nourish beneficial bacteria) or probiotics (live beneficial microbes), ideally guided by a clinician—especially in older adults or those taking multiple medications. Overall, while diet and lifestyle can’t replace dementia-specific medical care, microbiome-supportive habits may help support gut barrier health, reduce systemic inflammatory pressure, and promote healthier brain–immune interactions over time.

  • Lifestyle recommendations

    • Increase dietary fiber with a diverse range of minimally processed plant foods (vegetables, fruits, legumes, whole grains) to support beneficial gut microbes and SCFA production.
    • Aim for a gut-friendly eating pattern (e.g., Mediterranean-style) and limit ultra-processed foods and excess added sugars, which can promote dysbiosis and inflammation.
    • Maintain regular bowel habits (adequate hydration, consistent meal timing, and fiber titration if needed) to reduce constipation-related microbiome disruption.
    • Consider discussing prebiotics and/or probiotics with a clinician—especially if you have GI symptoms, antibiotic exposure, or known dysbiosis—to support a healthier microbiome.
    • Prioritize physical activity (as tolerated) and stress-management practices (sleep hygiene, mindfulness/relaxation), since both influence gut barrier function, inflammation, and brain health.
    • If you have risk factors or early symptoms, work with a healthcare professional on an individualized nutrition and supplement plan and ensure other dementia-relevant conditions (e.g., diabetes, hypertension) are well managed.

  • Nutrition recommendations

    • Increase dietary fiber gradually to support SCFA production (aim for a mix of soluble + insoluble fibers from oats, beans/lentils, chia/flax, fruits, and vegetables).
    • Eat a diverse “plant-forward” diet (30+ different plant foods per week when possible) to promote a resilient microbiome—especially minimally processed foods like berries, leafy greens, cruciferous vegetables, legumes, and whole grains.
    • Prioritize fermented foods for microbial diversity (e.g., yogurt/kefir with live cultures, sauerkraut, kimchi, tempeh) while monitoring tolerance; consider probiotic options to discuss with a clinician.
    • Use prebiotics and gut-supporting carbs strategically (onions, garlic, leeks, asparagus, bananas—especially slightly green bananas—oats, and barley) to nourish beneficial gut bacteria.
    • Limit ultra-processed foods, added sugars, and high saturated-fat patterns that can worsen dysbiosis and intestinal barrier function; choose healthier fats (olive oil, nuts, seeds, omega-3 sources like fatty fish).
    • Ensure adequate hydration and maintain regular bowel habits (fiber + fluids) to reduce constipation-related microbiome disruption and inflammation signals.

  • Supplement considerations

    For dementia, supplement strategies often focus on supporting a healthier gut microbiome and reducing inflammation pathways that may influence brain function. Key options include probiotics and prebiotics, which aim to promote beneficial bacterial populations and improve gut barrier integrity. Prebiotics such as inulin-type fibers and other fermentable fibers can support short-chain fatty acid (SCFA) production, including butyrate, which plays a role in calming intestinal inflammation and maintaining a healthy mucosal lining—processes that may indirectly affect neuroinflammation relevant to cognitive decline. Because probiotic effects can be strain-specific, it’s generally more useful to select products with well-documented strains and dosing rather than relying on broad “multi-strain” claims alone.

    Another consideration is targeting gut-derived inflammatory signals through anti-inflammatory and metabolic support. Omega-3 fatty acids (EPA/DHA) are sometimes considered because they may help modulate systemic inflammation, which overlaps with pathways thought to contribute to brain inflammation. For some individuals, supplements that support SCFA availability and gut motility—such as adequate fiber supplementation, magnesium (for bowel regularity in appropriate cases), or specific fiber blends—may help normalize bowel routines that dysbiosis tends to disrupt. In practice, gradual titration matters, since increasing fermentable fibers too quickly can worsen bloating or discomfort, especially in older adults.

    Finally, it’s important to consider safety and personalization, since dementia care often involves multiple medications and age-related changes in digestion. Clinicians may recommend discussing probiotics carefully if there’s immunosuppression, recent gastrointestinal illness, or the presence of indwelling medical devices. For those considering synbiotics (a combination of pre- and probiotics) or postbiotic products (microbial metabolites such as SCFA-related compounds), the goal is typically to strengthen microbial signaling without over-relying on live organisms. Overall, supplements are best viewed as adjuncts to a microbiome-supportive diet and routine—while monitoring for tolerability and coordinating with healthcare providers to match the supplement plan to the dementia subtype, GI symptoms, and medication profile.

  • Retesting / monitoring note

    For dementia-related goals tied to the gut–brain connection, retesting is typically focused on whether gut microbiome and related biological markers are changing after an intervention (for example, diet changes, fiber targets, pre/probiotic use, or management of constipation). In practice, many clinicians and researchers reassess after a sufficient “microbiome update” window—often around 8–12 weeks—because microbial communities and fermentation-driven metabolites (such as short-chain fatty acids) can shift within weeks, while improvements in gut barrier function and systemic inflammatory tone may take longer to become measurable. Retesting at a consistent interval helps distinguish normal variability from true response.

    Because dementia is complex and microbiome effects may be indirect, retesting should ideally include both gut-focused and brain-relevant context indicators. Gut-focused reassessment may include gastrointestinal symptom patterns (e.g., stool frequency/consistency, bloating), dietary adherence, and, when appropriate, stool-based metrics or blood markers that reflect inflammation and immune activation. If systemic inflammation markers are used, they are generally retested on a similar cadence (commonly 8–12 weeks), with interpretation always anchored to the person’s overall medical status, medications (notably antibiotics, anticholinergics, and anti-inflammatory agents), and other confounders that can strongly influence cognition and gut ecology.

    Finally, retesting recommendations should be individualized to dementia subtype risk, disease stage, and tolerability of gut interventions. For example, if a patient experiences gastrointestinal side effects from fiber escalation, pre/probiotics, or medication adjustments, retesting may be moved earlier to confirm the intervention is both safe and directionally effective. Reassessment of cognitive or functional outcomes (memory, attention, confusion severity, daily functioning) can be repeated over longer intervals—often 3–6 months—since cognitive change may lag behind gut and inflammatory shifts. Discussing the retesting plan with a clinician is important to ensure results translate into practical, sustainable microbiome-supportive strategies.

The importance of gut microbiome testing

  • Why testing matters

    Gut microbiome testing can help clarify whether an individual with dementia risk or symptoms may have gut dysbiosis—an imbalance that can influence inflammation, gut barrier integrity, and the production of neuroactive metabolites. By identifying patterns in microbial composition (and sometimes functional signals like SCFA-producing capacity), testing may offer clues about whether the gut environment is less supportive for processes linked to brain health, such as immune regulation and reduced systemic inflammation.

    In dementia, inflammation and stress-response pathways are thought to interact bidirectionally with the gut. When dysbiosis is present, it can be associated with increased intestinal permeability (often described as “leaky gut”), which may allow inflammatory signals and microbial byproducts to more easily affect circulation and, downstream, neuroinflammation. Microbiome testing can therefore be useful for understanding whether a person’s gut microbial ecology might be contributing to the inflammatory load that can worsen cognitive symptoms like confusion, slower processing, or reduced executive function.

    Testing also matters because it can guide more personalized, targeted interventions rather than relying on one-size-fits-all advice. Results can inform which dietary fiber sources, prebiotics, fermented foods, or probiotic strategies may be more likely to support a healthier microbial balance and strengthen gut barrier function—factors that may be relevant to maintaining cognitive well-being over time. Because causality and dementia subtypes are still being studied, testing should be viewed as a tool to support clinician-guided, individualized gut-focused care alongside standard medical management.

  • How InnerBuddies helps

    For dementia, the InnerBuddies test can help by assessing key features of a person’s gut microbiome that are often linked to inflammatory balance, gut barrier integrity, and the production of brain-relevant microbial metabolites. Because the gut–brain connection involves pathways such as immune signaling and metabolite generation (including SCFAs), the test may help reveal whether the gut environment is showing signs of dysbiosis—an imbalance that can contribute to a higher inflammatory load and potentially support neuroinflammation linked to cognitive decline.

    InnerBuddies may also help identify microbiome patterns that can be used to personalize nutrition and gut-support strategies rather than using generic recommendations. For example, results can inform which types of dietary fiber, prebiotics, fermented foods, or probiotic approaches may be more likely to support a healthier microbial ecosystem and strengthen the conditions that favor proper gut barrier function and reduced systemic inflammation—processes thought to be relevant to cognitive symptoms such as confusion, slower processing, and changes in executive function.

    Finally, gut microbiome testing can be a useful way to guide clinician-supported, individualized care alongside standard dementia management. While research on cause-and-effect and dementia subtypes is still evolving, InnerBuddies can provide actionable context about gut health that helps clinicians and patients consider targeted next steps. This can make it easier to monitor how interventions affect the gut ecosystem over time, supporting a more informed approach to brain health from the gut.

Medical Evidence

  • Scientific evidence level

    2 [weak: emerging but inconsistent; mainly association/preclinical with limited causal and no validated clinical utility]

  • Clinical relevance note

    Current clinical relevance is limited. While many studies report statistically significant differences between the gut microbiome of people with dementia and controls, these are not the same as validated, reproducible biomarkers. The field lacks consistent signatures across independent cohorts and lacks strong prospective demonstration that specific microbiome features reliably predict incident dementia or meaningful cognitive decline in populations without dementia at baseline.

    No microbiome-targeted intervention has strong evidence of improving dementia outcomes in real-world clinical settings. Even when mechanistic and preclinical findings are supportive, the absence of well-powered, dementia-focused RCTs with clinically meaningful endpoints (and durable effects) means actionable guidance is not currently justified. Methodological inconsistency (batch effects, sequencing platforms, sampling/stool handling, confounder control) and reverse causality further weaken translation. Therefore, microbiome research should be viewed as hypothesis-generating and potentially supportive of future therapeutic development, not as an established clinical tool for dementia at this time.

Title Journal Year Link
Intestinal microbiota and risk of dementia: a population-based study Nature Medicine 2022 View →
Gut microbiota and Alzheimer's disease: advances, challenges and perspectives Cell Host & Microbe 2021 View →
Microbiome-based therapeutic strategies for neurodegenerative diseases Trends in Neurosciences 2020 View →
The gut microbiome in Parkinson’s disease and dementia with Lewy bodies Molecular Neurodegeneration 2019 View →
Gut microbiota composition and Alzheimer's disease: a systematic review and meta-analysis Journal of Alzheimer's Disease 2018 View →

Frequently Asked Questions

    ¿Qué es la conexión cerebro-intestino en la demencia?
    Es la idea de que los microorganismos del intestino pueden influir en la salud cerebral mediante metabolitos, señales inmunes y vías nerviosas; es un área de investigación, no una causa comprobada.
    ¿Cómo pueden las bacterias intestinales influir en la cognición?
    Producen metabolitos como ácidos grasos de cadena corta (SCFA) y otras señales que pueden afectar la inflamación, la barrera intestinal y la química del cerebro; la evidencia está evolucionando.
    ¿Qué es el intestino permeable y cómo se relaciona con la demencia?
    Una permeabilidad intestinal aumentada puede permitir que señales inflamatorias entren en la sangre; tema de estudio, no diagnóstico.
    ¿Qué pasos dietéticos pueden apoyar la salud intestinal?
    Enfoque en una dieta rica en fibra, con una diversidad de plantas mínimamente procesadas y comidas regulares; hable con un profesional sobre fuentes de fibra y probióticos si es adecuado.
    ¿Qué pruebas existen para evaluar el microbioma en el contexto de la demencia?
    Las pruebas pueden mostrar patrones de disbiosis y capacidad de producir SCFA; no son diagnósticas de demencia y deben interpretarse con un profesional.
    ¿Puede mejorar la salud intestinal ralentizar la demencia?
    No hay evidencia de cura o prevención; algunas estrategias pueden apoyar la salud cerebral general y reducir la inflamación como parte de un cuidado integral.
    ¿Deben tomar probióticos o prebióticos las personas con demencia?
    Hable con un profesional; algunos pueden ayudar, los efectos varían y hay consideraciones de seguridad.
    ¿Cuál es la prevalencia de la demencia en el mundo?
    Alrededor de 55 millones de personas; aumenta con la edad y varía por región.
    ¿Qué es InnerBuddies y para qué sirve?
    Es un test del microbioma descrito en el contenido; guía estrategias personalizadas de apoyo intestinal bajo supervisión clínica; no es una herramienta diagnóstica.
    ¿Qué síntomas son comunes en la demencia?
    Pérdida de memoria que afecta la vida diaria, dificultad para encontrar palabras, confusión, juicio pobre, problemas de planificación, cambios de humor o comportamiento, agitación en entornos desconocidos.
    ¿Qué significa disbiosis?
    Desequilibrio del microbioma intestinal, a menudo con menor diversidad y patrones inflamatorios; no es un diagnóstico por sí solo.
    ¿Qué consejos de estilo de vida apoyan la salud intestinal y cerebral?
    Movimiento regular, dieta rica en fibra y diversa basada en plantas, poco procesada; discutir probióticos con un profesional; buscar la salud general.

    Hear from our satisfied customers!

    • "I would like to let you know how excited I am. We had been on the diet for about two months (my husband eats with us). We felt better with it, but how much better was really only noticed during the Christmas vacations when we had received a large Christmas package and didn't stick to the diet for a while. Well that did give motivation again, because what a difference in gastrointestinal symptoms but also energy in both of us!"

      - Manon, age 29 -

    • "Super help!!! I was already well on my way, but now I know for sure what I should and should not eat, drink. I have been struggling with stomach and intestines for so long, hope I can get rid of it now."

      - Petra, age 68 -

    • "I have read your comprehensive report and advice. Many thanks for that and very informative. Presented in this way, I can certainly move forward with it. Therefore no new questions for now. I will gladly take your suggestions to heart. And good luck with your important work."

      - Dirk, age 73 -